Goldman Sachs’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.7M | Buy |
1,876,750
+441,023
| +31% | +$4.84M | ﹤0.01% | 2554 |
|
|
2025
Q4 | $17.8M | Sell |
1,435,727
-96,607
| -6% | -$1.28M | ﹤0.01% | 2501 |
|
|
2025
Q3 | $22M | Sell |
1,532,334
-193,195
| -11% | -$2.65M | ﹤0.01% | 2164 |
|
|
2025
Q2 | $21.2M | Buy |
1,725,529
+65,018
| +4% | +$944K | ﹤0.01% | 2080 |
|
|
2025
Q1 | $36.5M | Buy |
1,660,511
+35,790
| +2% | +$842K | 0.01% | 1464 |
|
|
2024
Q4 | $36.8M | Buy |
1,624,721
+318,203
| +24% | +$6.95M | 0.01% | 1557 |
|
|
2024
Q3 | $23.7M | Buy |
1,306,518
+701,397
| +116% | +$16.3M | ﹤0.01% | 1911 |
|
|
2024
Q2 | $17.6M | Buy |
605,121
+12,009
| +2% | +$356K | ﹤0.01% | 1987 |
|
|
2024
Q1 | $21M | Sell |
593,112
-59,042
| -9% | -$2.36M | ﹤0.01% | 1799 |
|
|
2023
Q4 | $28.4M | Sell |
652,154
-31,139
| -5% | -$1.23M | 0.01% | 1595 |
|
|
2023
Q3 | $26.1M | Buy |
683,293
+70,105
| +11% | +$2.95M | 0.01% | 1579 |
|
|
2023
Q2 | $25.2M | Sell |
613,188
-188,902
| -24% | -$9.09M | 0.01% | 1652 |
|
|
2023
Q1 | $46M | Sell |
802,090
-316,288
| -28% | -$17.8M | 0.01% | 1123 |
|
|
2022
Q4 | $62.7M | Buy |
1,118,378
+140,707
| +14% | +$7.16M | 0.02% | 990 |
|
|
2022
Q3 | $41.4M | Sell |
977,671
-488,541
| -33% | -$25M | 0.01% | 1252 |
|
|
2022
Q2 | $79.2M | Sell |
1,466,212
-53,531
| -4% | -$3.21M | 0.02% | 830 |
|
|
2022
Q1 | $97.7M | Buy |
1,519,743
+37,025
| +2% | +$2.44M | 0.02% | 782 |
|
|
2021
Q4 | $99.3M | Buy |
1,482,718
+629,202
| +74% | +$42.6M | 0.02% | 826 |
|
|
2021
Q3 | $58.4M | Sell |
853,516
-27,554
| -3% | -$1.95M | 0.01% | 1170 |
|
|
2021
Q2 | $60.1M | Buy |
881,070
+86,991
| +11% | +$6.15M | 0.01% | 1105 |
|
|
2021
Q1 | $54.9M | Buy |
794,079
+239,762
| +43% | +$16.2M | 0.01% | 1109 |
|
|
2020
Q4 | $36M | Sell |
554,317
-190,774
| -26% | -$10.3M | 0.01% | 1386 |
|
|
2020
Q3 | $35.2M | Buy |
745,091
+83,427
| +13% | +$3.97M | 0.01% | 1280 |
|
|
2020
Q2 | $31.1M | Sell |
661,664
-324,459
| -33% | -$15.9M | 0.01% | 1328 |
|
|
2020
Q1 | $44M | Buy |
986,123
+280,818
| +40% | +$14.7M | 0.02% | 958 |
|
|
2019
Q4 | $41.1M | Buy |
705,305
+392,285
| +125% | +$23.4M | 0.01% | 1300 |
|
|
2019
Q3 | $18.8M | Buy |
313,020
+12,176
| +4% | +$725K | 0.01% | 1830 |
|
|
2019
Q2 | $16.8M | Buy |
300,844
+40,759
| +16% | +$2.1M | ﹤0.01% | 1986 |
|
|
2019
Q1 | $14.5M | Sell |
260,085
-42,534
| -14% | -$2.17M | ﹤0.01% | 2131 |
|
|
2018
Q4 | $13.6M | Buy |
302,619
+32,061
| +12% | +$1.76M | ﹤0.01% | 2116 |
|
|
2018
Q3 | $17.8M | Sell |
270,558
-747,738
| -73% | -$46.5M | ﹤0.01% | 2012 |
|
|
2018
Q2 | $65.6M | Sell |
1,018,296
-104,227
| -9% | -$6.45M | 0.02% | 1017 |
|
|
2018
Q1 | $62.1M | Buy |
1,122,523
+64,816
| +6% | +$3.4M | 0.02% | 1054 |
|
|
2017
Q4 | $50.6M | Sell |
1,057,707
-80,983
| -7% | -$3.96M | 0.01% | 1285 |
|
|
2017
Q3 | $57.5M | Sell |
1,138,690
-51,180
| -4% | -$2.63M | 0.01% | 1178 |
|
|
2017
Q2 | $64.9M | Buy |
1,189,870
+101,092
| +9% | +$4.83M | 0.02% | 1072 |
|
|
2017
Q1 | $45.9M | Sell |
1,088,778
-123,166
| -10% | -$5.26M | 0.01% | 1279 |
|
|
2016
Q4 | $52M | Buy |
1,211,944
+96,188
| +9% | +$3.91M | 0.01% | 1244 |
|
|
2016
Q3 | $46.1M | Sell |
1,115,756
-212,504
| -16% | -$8.9M | 0.01% | 1267 |
|
|
2016
Q2 | $53M | Sell |
1,328,260
-67,864
| -5% | -$2.44M | 0.02% | 1076 |
|
|
2016
Q1 | $47M | Buy |
1,396,124
+117,020
| +9% | +$3.64M | 0.02% | 1118 |
|
|
2015
Q4 | $43.3M | Sell |
1,279,104
-73,062
| -5% | -$2.28M | 0.01% | 1227 |
|
|
2015
Q3 | $40.3M | Buy |
1,352,166
+1,122,550
| +489% | +$35.1M | 0.01% | 1197 |
|
|
2015
Q2 | $6.32M | Sell |
229,616
-1,566,212
| -87% | -$41.7M | ﹤0.01% | 2752 |
|
|
2015
Q1 | $45.3M | Sell |
1,795,828
-168,491
| -9% | -$3.98M | 0.01% | 1173 |
|
|
2014
Q4 | $43.5M | Buy |
1,964,319
+388,989
| +25% | +$7.89M | 0.01% | 1217 |
|
|
2014
Q3 | $32M | Buy |
1,575,330
+596,352
| +61% | +$11.9M | 0.01% | 1427 |
|
|
2014
Q2 | $18.8M | Buy |
978,978
+971,093
| +12,316% | +$18.1M | 0.01% | 1835 |
|
|
2014
Q1 | $148K | Sell |
7,885
-143,260
| -95% | -$2.76M | ﹤0.01% | 6246 |
|
|
2013
Q4 | $2.95M | Buy |
151,145
+77,242
| +105% | +$1.42M | ﹤0.01% | 3649 |
|
|
2013
Q3 | $1.22M | Buy |
73,903
+12,670
| +21% | +$203K | ﹤0.01% | 4424 |
|
|
2013
Q2 | $917K | Buy |
+61,233
| New | +$897K | ﹤0.01% | 4461 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Goldman Sachs's IART Position: Q1 2026 in Review
Goldman Sachs increased its Integra LifeSciences (IART) stake by 31% in Q1 2026, buying an estimated $4.84M and bringing the position to 1,876,750 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2554.
Goldman Sachs first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $99.3M in Q4 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Goldman Sachs held 1,876,750 shares of Integra LifeSciences worth $17.7M as of Q1 2026.
- Goldman Sachs bought 441,023 Integra LifeSciences shares in Q1 2026, an estimated $4.84M.
- Integra LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2554 holding.
- Goldman Sachs first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Integra LifeSciences position peaked at $99.3M in Q4 2021.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.